journal article·2023-11Open access

A Balance between Inter‐ and Intra‐Microgel Mechanics Governs Stem Cell Viability in Injectable Dynamic Granular Hydrogels

Cameron D. Morley, Erika A. Ding, Emily M. Carvalho, Sanjay Kumar

Advanced Materials· Volume 35· Issue 44

Abstract

Abstract Injectable hydrogels are increasingly explored for the delivery of cells to tissue. These materials exhibit both liquid‐like properties, protecting cells from mechanical stress during injection, and solid‐like properties, providing a stable 3D engraftment niche. Many strategies for modulating injectable hydrogels tune liquid‐ and solid‐like material properties simultaneously, such that formulation changes designed to improve injectability can reduce stability at the delivery site. The ability to independently tune liquid‐ and solid‐like properties would greatly facilitate formulation development. Here, such a strategy is presented in which cells are ensconced in the pores between microscopic granular hyaluronic acid (HA) hydrogels (microgels), where elasticity is tuned with static covalent intra‐microgel crosslinks and flowability with mechanosensitive adamantane‐cyclodextrin (AC) inter‐microgel crosslinks. Using the same AC‐free microgels as a 3D printing support bath, the location of each cell is preserved as it exits the needle, allowing identification of the mechanism driving mechanical trauma‐induced cell death. The microgel AC concentration is varied to find the threshold from microgel yielding‐ to AC interaction‐dominated injectability, and this threshold is exploited to fabricate a microgel with better injection‐protecting performance. This delivery strategy, and the balance between intra‐ and inter‐microgel properties it reveals, may facilitate the development of new cell injection formulations.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Hydrogels: synthesis, properties, applications · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering University of California Berkeley CA 94720 USA

Department of Chemical and Biomolecular Engineering University of California Berkeley CA 94720 USA

Department of Bioengineering and Therapeutic Sciences University of California San Francisco CA 94158 USA

Funding

Bayer Corporation · National Institutes of Health · National Science Foundation

References (44)

Show source-provided references
1. 10.3390/ma303174610.3390/ma3031746 ↗
2. 10.1016/j.biomaterials.2010.05.01710.1016/j.biomaterials.2010.05.017 ↗
3. 10.1016/j.biomaterials.2017.05.00810.1016/j.biomaterials.2017.05.008 ↗
4. 10.1016/j.biomaterials.2011.12.04410.1016/j.biomaterials.2011.12.044 ↗
5. 10.1016/j.jtcvs.2015.07.03510.1016/j.jtcvs.2015.07.035 ↗
6. 10.1016/j.biomaterials.2013.03.09510.1016/j.biomaterials.2013.03.095 ↗
7. 10.1021/acsbiomaterials.9b0038910.1021/acsbiomaterials.9b00389 ↗
8. 10.1089/ten.tea.2011.039110.1089/ten.tea.2011.0391 ↗
9. 10.1021/acs.chemrev.0c0117710.1021/acs.chemrev.0c01177 ↗
10. 10.1038/nchem.117410.1038/nchem.1174 ↗
11. 10.1038/nmat247310.1038/nmat2473 ↗
12. 10.1016/j.progpolymsci.2014.07.00610.1016/j.progpolymsci.2014.07.006 ↗
13. 10.1021/acsami.8b0731010.1021/acsami.8b07310 ↗
14. 10.1021/acs.chemrev.2c0017910.1021/acs.chemrev.2c00179 ↗
15. 10.1002/jbm.a.3454610.1002/jbm.a.34546 ↗
16. 10.1002/btm2.1014710.1002/btm2.10147 ↗
17. 10.2217/nnm-2021-002510.2217/nnm-2021-0025 ↗
18. 10.1002/adhm.20230002910.1002/adhm.202300029 ↗
19. 10.1016/j.actbio.2021.12.03610.1016/j.actbio.2021.12.036 ↗
20. 10.1021/acsbiomaterials.1c0027510.1021/acsbiomaterials.1c00275 ↗
21. 10.1039/c0cs00153h10.1039/c0cs00153h ↗
22. 10.1038/s41467-019-10919-110.1038/s41467-019-10919-1 ↗
23. 10.1002/advs.20180107610.1002/advs.201801076 ↗
24. 10.1002/adhm.20220002710.1002/adhm.202200027 ↗
25. 10.1039/D0SM00517G10.1039/D0SM00517G ↗
26. 10.1002/smll.20220111510.1002/smll.202201115 ↗
27. 10.1002/adma.20227009210.1002/adma.202270092 ↗
28. 10.1002/anbr.20220003010.1002/anbr.202200030 ↗
29. 10.1016/j.copbio.2018.11.00110.1016/j.copbio.2018.11.001 ↗
30. 10.1002/adma.20170591210.1002/adma.201705912 ↗
31. 10.1016/j.biomaterials.2011.07.00510.1016/j.biomaterials.2011.07.005 ↗
32. 10.1039/B916933D10.1039/B916933D ↗
33. 10.1016/j.stem.2014.09.01710.1016/j.stem.2014.09.017 ↗
34. 10.1038/nature1064810.1038/nature10648 ↗
35. 10.1038/srep3997510.1038/srep39975 ↗
36. 10.1016/S0006-3495(72)86085-510.1016/S0006-3495(72)86085-5 ↗
37. 10.1002/sctm.20-024210.1002/sctm.20-0242 ↗
38. 10.1039/C7SM01518F10.1039/C7SM01518F ↗
39. 10.1163/156856299X0012610.1163/156856299X00126 ↗
40. Lee M. S. · Rev. Cardiovasc. Med. · 2004 · 5 · 82
41. 10.3390/gels701000710.3390/gels7010007 ↗
42. 10.1016/j.addr.2007.08.00710.1016/j.addr.2007.08.007 ↗
43. 10.1002/anie.20170568410.1002/anie.201705684 ↗
44. 10.1007/978-1-61779-105-5_2810.1007/978-1-61779-105-5_28 ↗